文献速递消化内镜消化道肿瘤与早癌

40至49岁平均风险成人腺瘤检出率与进展期肿瘤患病率:系统综述与荟萃分析

Adenoma detection and advanced neoplasia prevalence in average-risk adults aged 40 to 49 years: a systematic review and meta-analysis of colonoscopy-based studies.
PubMed 文献 · Gastrointest Endosc · 2026-06-05

汇总ADR从40-44岁的13.4%升至45-49岁的18.4%,AN从3.3%升至4.5%;45-49岁AN患病率在部分队列中与50岁出头人群相当。

要点

  • 40-44岁汇总ADR为13.4%,45-49岁为18.4%
  • 40-44岁汇总AN患病率为3.3%,45-49岁为4.5%
  • 45-49岁AN负担接近部分50岁出头对照人群

核心结论

  • 45-49岁平均风险成人腺瘤和AN负担具有临床意义,超过40-44岁人群,并在部分队列中接近50岁出头对照人群。

研究设计与样本

  • 系统综述与荟萃分析,检索PubMed、Web of Science和Scopus(2010年1月1日至2025年8月8日)。
  • 纳入报告40-44岁和/或45-49岁结局的流行病学研究,排除仅报告「<50岁」汇总类别的研究。

主要发现

  • 汇总ADR从40-44岁的13.4%(95%CI 7.4-20.9;I2=99.8%)升至45-49岁的18.4%(95%CI 12.8-24.8;I2=99.6%)。
  • 汇总AN患病率从40-44岁的3.3%(95%CI 2.3-4.6;I2=97.5%)升至45-49岁的4.5%(95%CI 3.5-5.7;I2=97.4%)。
  • 在多个队列中,45-49岁人群的AN患病率与50岁出头对照人群相当。
  • 敏感性和探索性分析得出了一致的估计值。

临床怎么用

  • 为结直肠癌筛查启动年龄的讨论提供了基于结肠镜的证据。

局限性

  • 研究间异质性高(ADR的I2为99.8%和99.6%,AN的I2为97.5%和97.4%)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: The prevalence of adenomas and advanced neoplasia (AN) in average-risk adults younger than 50 years remains incompletely characterized. We performed a systematic review and meta-analysis to estimate adenoma detection rate (ADR) and AN prevalence in average-risk individuals aged 40 to 49 years. METHODS: PubMed (MEDLINE), Web of Science, and Scopus were searched from January 1, 2010, to August 8, 2025. Epidemiologic studies reporting outcomes for individuals aged 40 to 44 and/or 45 to 49 years were included; studies reporting only an aggregated "<50 years" category were excluded. Quantitative pooling was restricted to average-risk and screening-equivalent populations, excluding cohorts enriched for high-risk symptoms or family history. Random-effects meta-analyses were performed with prespecified sensitivity analyses. RESULTS: Nineteen studies including 7.2 million colonoscopies met the inclusion criteria for qualitative synthesis and 16 for quantitative meta-analysis. Pooled ADR increased from 13.4% (95% CI, 7.4-20.9; I2 = 99.8%) at ages 40 to 44 to 18.4% (95% CI, 12.8-24.8; I2 = 99.6%) at ages 45 to 49. Pooled AN increased from 3.3% (95% CI, 2.3-4.6; I2 = 97.5%) to 4.5% (95% CI, 3.5-5.7; I2 = 97.4%). In several cohorts, AN prevalence in individuals aged 45 to 49 years was comparable to that observed in early-50s comparator groups. Sensitivity and exploratory analyses yielded consistent estimates. CONCLUSIONS: Average-risk adults aged 45 to 49 years demonstrated a clinically meaningful burden of adenomas and AN, exceeding that of 40- to 44-year-olds and approaching early-50s comparator groups in several cohorts. These findings provide colonoscopy-based evidence relevant to ongoing discussions regarding the optimal age for colorectal cancer screening initiation.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Bernardes C, Bodião S, Rocha M, et al. Adenoma detection and advanced neoplasia prevalence in average-risk adults aged 40 to 49 years: a systematic review and meta-analysis of colonoscopy-based studies. Gastrointest Endosc. 2026. PMID: 42250772. doi:10.1016/j.gie.2026.05.038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。